XERIS BIOPHARMA HOLDINGS INC's ticker is and the CUSIP is 98422E103. A total of 106 filers reported holding XERIS BIOPHARMA HOLDINGS INC in Q2 2023. The put-call ratio across all filers is 0.13 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $710,244 | +27.8% | 315,664 | +25.5% | 0.00% | – |
| Q1 2024 | $555,700 | -8.6% | 251,448 | -2.8% | 0.00% | – |
| Q4 2023 | $607,919 | +146.0% | 258,689 | +94.7% | 0.00% | – |
| Q3 2023 | $247,082 | -57.9% | 132,840 | -40.7% | 0.00% | – |
| Q2 2023 | $587,252 | +189.3% | 224,142 | +80.0% | 0.00% | – |
| Q1 2023 | $203,025 | -6.8% | 124,555 | -24.0% | 0.00% | – |
| Q4 2022 | $217,908 | +113988.0% | 163,840 | +33.6% | 0.00% | – |
| Q3 2022 | $191 | +10.4% | 122,646 | +9.0% | 0.00% | – |
| Q2 2022 | $173 | -100.0% | 112,540 | -84.5% | 0.00% | – |
| Q1 2022 | $1,857,000 | +178.4% | 725,255 | +218.5% | 0.00% | – |
| Q4 2021 | $667,000 | – | 227,691 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CAXTON CORP | 5,113,348 | $11,505,033 | 58.31% |
| Rosalind Advisors, Inc. | 3,120,170 | $7,020,382 | 5.40% |
| MPM BioImpact LLC | 4,830,526 | $10,868,684 | 1.69% |
| Knott David M Jr | 820,000 | $1,845 | 0.74% |
| CenterBook Partners LP | 1,465,875 | $3,298,219 | 0.20% |
| Redmile Group, LLC | 1,046,587 | $2,354,821 | 0.14% |
| Alpine Global Management, LLC | 300,000 | $675,000 | 0.12% |
| GSA CAPITAL PARTNERS LLP | 605,663 | $1,363 | 0.10% |
| Invenomic Capital Management LP | 592,078 | $1,332,176 | 0.06% |
| Powell Investment Advisors, LLC | 50,000 | $112,500 | 0.06% |